Safe Orthopaedics SA (ALSAF) - Total Assets
Based on the latest financial reports, Safe Orthopaedics SA (ALSAF) holds total assets worth €7.94 Million EUR (≈ $9.28 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Safe Orthopaedics SA cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Safe Orthopaedics SA - Total Assets Trend (2012–2024)
This chart illustrates how Safe Orthopaedics SA's total assets have evolved over time, based on quarterly financial data. See ALSAF net asset value for net asset value and shareholders' equity analysis.
Safe Orthopaedics SA - Asset Composition Analysis
Current Asset Composition (December 2024)
Safe Orthopaedics SA's total assets of €7.94 Million consist of 63.4% current assets and 36.6% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €317.00K | 2.9% |
| Accounts Receivable | €3.42 Million | 31.0% |
| Inventory | €3.40 Million | 30.8% |
| Property, Plant & Equipment | €2.50 Million | 22.7% |
| Intangible Assets | €148.00K | 1.3% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2012–2024)
This chart illustrates how Safe Orthopaedics SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see ALSAF stock market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Safe Orthopaedics SA's current assets represent 63.4% of total assets in 2024, a decrease from 76.4% in 2012.
- Cash Position: Cash and equivalents constituted 2.9% of total assets in 2024, down from 57.2% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, a decrease from 8.0% in 2012.
- Asset Diversification: The largest asset category is accounts receivable at 31.0% of total assets.
Safe Orthopaedics SA Competitors by Total Assets
Key competitors of Safe Orthopaedics SA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Autek China Inc
SHE:300595
|
China | CN¥6.40 Billion |
|
Zhejiang Gongdong Medical Technology Co Ltd
SHG:605369
|
China | CN¥2.19 Billion |
|
MEDIMI AB AK
F:79T
|
Germany | €1.70 Million |
|
I.Ceram SA
PA:ALICR
|
France | €3.91 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.33 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$135.84 Million |
|
Austco Healthcare Ltd
AU:AHC
|
Australia | AU$91.07 Million |
Safe Orthopaedics SA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.20 | 0.04 | 1.23 |
| Quick Ratio | 0.04 | 0.02 | 0.88 |
| Cash Ratio | 0.01 | 0.00 | 0.00 |
| Working Capital | €-17.29 Million | €-198.73 Million | €1.20 Million |
Safe Orthopaedics SA - Advanced Valuation Insights
This section examines the relationship between Safe Orthopaedics SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.40 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -85.8% |
| Total Assets | €11.03 Million |
| Market Capitalization | $135.60K USD |
Valuation Analysis
Below Book Valuation: The market values Safe Orthopaedics SA's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Safe Orthopaedics SA's assets decreased by 85.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Safe Orthopaedics SA (2012–2024)
The table below shows the annual total assets of Safe Orthopaedics SA from 2012 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €11.03 Million ≈ $12.90 Million |
-85.84% |
| 2023-12-31 | €77.92 Million ≈ $91.10 Million |
+371.76% |
| 2022-12-31 | €16.52 Million ≈ $19.31 Million |
+11.01% |
| 2021-12-31 | €14.88 Million ≈ $17.40 Million |
+3.72% |
| 2020-12-31 | €14.35 Million ≈ $16.77 Million |
+154.29% |
| 2019-12-31 | €5.64 Million ≈ $6.60 Million |
-34.19% |
| 2018-12-31 | €8.57 Million ≈ $10.02 Million |
+6.39% |
| 2017-12-31 | €8.06 Million ≈ $9.42 Million |
+0.67% |
| 2016-12-31 | €8.00 Million ≈ $9.36 Million |
-23.46% |
| 2015-12-31 | €10.46 Million ≈ $12.23 Million |
+96.49% |
| 2014-12-31 | €5.32 Million ≈ $6.22 Million |
+29.21% |
| 2013-12-31 | €4.12 Million ≈ $4.82 Million |
+17.55% |
| 2012-12-31 | €3.50 Million ≈ $4.10 Million |
-- |
About Safe Orthopaedics SA
Safe Orthopaedics SA, a medical technology company, develops and markets ready-to-use implants and sterile instrumentation for spinal surgery in France. It offers SteriSpine PS, an all-round kit for open, mini open, and MIS surgeries, as well as percutaneous kit; SteriSpine VA, a product platform for ready to use Kyphoplasty and Cement systems; SteriSpine LC, a ready to use instrumentation for lu… Read more